-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: Medicaid
Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics
I was recently asked what the single biggest threat to the biotechnology industry is today. My answer was immediate – the biggest threat to biotech innovation is the unsustainable mismatch of spending and revenue in the U.S. federal budget. The enormous national debt and the huge annual budget deficits that feed it endanger America’s entire economic future – but the nation’s dire fiscal situation is particularly threatening to our industry. Part of the reason for Read More >
Jim's Corner
Leave a comment
Email This Post
Tags: 2013 BIO International Convention, BIO Events, BIO International Convention, budget deficit, debt ceiling, Events, FDA, federal budget, finance policy, Food and Drug Administration, Health Care, Medicaid, medicare, National Institutes of Health, NIH, simpson-bowles
Tags: 2013 BIO International Convention, BIO Events, BIO International Convention, budget deficit, debt ceiling, Events, FDA, federal budget, finance policy, Food and Drug Administration, Health Care, Medicaid, medicare, National Institutes of Health, NIH, simpson-bowles
Biotechnology Innovation: Impact of Health Reform and Deficit Control
By Alyson Pusey, BIO. With many governors around the country facing budget shortfalls, “the action is all in the states” in terms of health care cuts and cost-savings solutions, according to panelists participating. The current fiscal environment has forced cash-strapped states to look at their Medicaid programs for ways to rein in costs, and according to panelists, state lawmakers will continue to do so for the foreseeable future. For example, as a result of the Read More >
